Archives

FDA Says No To Avanir Pharma’s Migraine Drug-Device AVP-825

The FDA has declined to approve Avanir Pharmaceuticals Inc.’s (AVNR: Quote) investigational drug-device combination product AVP-825 for the treatment of migraine.
AVP-825 delivers sumatriptan powder intranasally utilizing a novel Breath Powered delive…

WSJ: GoPro Plans To Launch Own Consumer Drones In 2015

Action-sports camera maker GoPro Inc. (GPRO: Quote) is developing its own line of consumer drones to expand from its core business, the Wall Street Journal reported Tuesday, citing people familiar with the company’s plans.
According to the WSJ report,…

EE Confirms Exploratory Talks With BT Group

EE Ltd., the UK’s largest mobile operator, said Wednesday that its joint shareholders, Deutsche Telekom AG (DTEGY.PK) and Orange SA (ORAN: Quote), are in exploratory talks about a sale of the company to fixed-line operator BT Group plc. (BT_A.L,BT: Qu…

Why Tecfidera Drug Label Is Updated…

The drug label of Biogen Idec Inc.’s (BIIB: Quote) Tecfidera, an oral therapy for multiple sclerosis, has been updated to include information describing the case of a rare and serious brain infection called PML associated with its use, the FDA announc…